Advertise on podcast: Pain Matters Podcast Network

Episode Summary: Welcome back to the Pain Matters podcast, where Dr. Sudheer Potru, DO, alongside Dr. Mustafa Broachwala, DO, delves into crucial topics on acute low back pain guidelines. Featuring insights from Dr. Jessica Oswald, MD, MPH and Dr. Devin Kansagara, MD, FACP, this episode focuses on the implications of FDA-funded guidelines, co-sponsored by the American Academy of Pain Medicine. This expert panel discusses the nuances of managing acute low back pain, emphasizing evidence-based practices to improve patient care. Throughout the episode, Dr. Oswald and Dr. Kansagara explore the guidelines’ perspectives on imaging, opioids, and alternative therapies. Discussing the common tendency to order imaging tests for low back pain, the conversation shifts to effective patient communication and strategies for reducing unnecessary imaging. They also address opioid use, highlighting its role as a third-line option and discussing the importance of evaluating individual patient needs to optimize function without escalating risks. The episode also emphasizes non-pharmacological interventions, such as early physical therapy, and overcoming challenges related to access bottlenecks. Key Takeaways: Guideline Applicability: Emphasizing the acute stage, the guidelines apply to pain lasting less than six weeks.Imaging Insights: Many clinicians still rely heavily on imaging for acute low back pain despite evidence showing limited benefit. Patient communication is crucial in managing expectations.Opioid Recommendations: Reserved as a third-line treatment, opioids are not usually recommended for acute low back pain due to risks outweighing benefits in most cases.Non-Pharmacological Therapies: Early engagement in physical therapy and alternative therapies can enhance long-term recovery, highlighting the importance of patient education and movement.Epidural Injections and Controversies: The discussion points out the limited evidence for epidural steroid injections, prompting nuances in clinical decision-making amid evidence shortages.

Episode Summary: In this episode of the Pain Matters podcast, Host Sudheer Potru, DO, FASA, FASAM, and Co-Host Zafeer Baber, MD, offer a comprehensive discussion of the (relatively) new analgesic medication suzetrigine, emphasizing its impact on acute pain management. Approved by the FDA in January 2025, this oral medication offers promising alternatives for moderate-to-severe postoperative pain management. Delving into its mechanism, the conversation also covers the history of voltage-gated sodium (“NAV”) 1.8 channel research and its implications for patient care. Throughout the episode, the hosts highlight suzetrigine’s unique mechanism of action, acting preferentially on the NAV 1.8 sodium channels located predominantly in the peripheral nervous system. The dialogue explores its advantages over traditional opioids, including reduced side effects such as sedation and constipation, making it an attractive option for enhancing postoperative recovery protocols like ERAS (Enhanced Recovery After Surgery). The conversation expands on the complexities of treating chronic pain and the potential for new Nav channel-targeting agents to revolutionize pain management employing targeted strategies. Key Takeaways: Understanding Suzetragine: Suzetragine acts as a novel analgesic focusing on the NAV 1.8 sodium channels, offering reduced side effects compared to opioids, especially in postoperative settings.Mechanism and Discovery: The NAV 1.8 sodium channel, essential for pain signal propagation, was key to designing suzetrogine. Its function was inadvertently highlighted by genetic mutations found in individuals who couldn’t feel pain due to alterations in similar channels.Economic and Clinical Implications: Although suzetrogine is more expensive than traditional pain medications, its potential to reduce hospital-acquired complications could justify its cost in clinical settings.Future Prospects in Chronic Pain: Ongoing research into suzetrogine’s effectiveness for conditions like diabetic neuropathy could offer new opportunities in managing chronic pain.Broader Pharmacological Impacts: The development of NAV channel-targeted medications marks a significant milestone, signaling a shift towards more specialized pain management options.*Views expressed by our hosts and guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

Episode Summary: In this engaging and informative episode of the Pain Matters Podcast, hosts Sudheer Potru, DO, FASA, FASAM, and Co-Host Zafeer Baber, MD, sit down with renowned chronic pain advocate, Tom Norris. With a four-decade-long journey through the challenges of chronic pain, Tom shares his invaluable insights regarding the newly drafted Acute Low Back Pain Guideline** (drafted by the Pacific Northwest Evidence-based Practice Center at Oregon Health & Science University (OHSU EPC) and the American Academy of Pain Medicine), recently submitted to Pain Medicine Journal and currently under review. His unique perspective underscores the critical need for clear communication and collaboration between clinicians and patients, especially in the context of guideline development and healthcare delivery.  Throughout the discussion, the trio delves into practical strategies for managing acute and chronic pain, emphasizing the importance of patient-centered communication, the role of alternative therapies, and the power of support groups. Tom candidly discusses his military background and how it has shaped his ability to advocate effectively for himself and others within the medical community. The episode also explores the significance of understanding non-pharmacologic pain management techniques, such as virtual reality, acupuncture, and Tai Chi, and the need for greater awareness and education on these options. Anchored by Tom's wealth of experience and wisdom, this episode serves as a robust resource for both healthcare providers and patients seeking to enhance their pain management approaches.   Key Takeaways: Patient-Centered Communication: Building trust and understanding between clinicians and patients is crucial in effectively managing pain and implementing guidelines.  Integrative and Alternative Therapies: Non-drug approaches like acupuncture, virtual reality, and Tai Chi can be beneficial in managing pain, but public awareness about these methods is limited.  Support Groups' Role: Connecting with others facing similar pain challenges can provide essential support and insights, offering solace and practical advice.   Empowering Patients: Patients should proactively educate themselves, prepare questions for their providers, and seek various treatment avenues to optimize their care.  Guideline Development Insight: Having patients involved in the creation of medical guidelines ensures that the recommendations are practical and resonate with those they are designed to help. *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.   **The Pacific Northwest Evidence-based Practice Center (PNW-EPC) at Oregon Health & Science University (OHSU) is partnered with AAPM for the development of an evidence-based clinical practice guideline on the assessment and management of acute low back pain (ALBP). This project was financially supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award [FAIN] totaling $1,999,980.00, with 100 percent funded by FDA/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, FDA, HHS, or the U.S. Government. The funders had no decision-making role in designing and conducting systematic review, data collection, analysis, and interpretation of the data or approval privilege on the recommendation and good practice statements. As requested, the FDA provided nonbinding feedback and technical support to the guideline panel and methodological team.  A methodologically rigorous systematic review  on assessment and management of ALBP was conducted by the PNW-EPC to provide evidence for guideline development. An independent, multidisciplinary guideline development used evidence from the systematic review to formulation evidence-based clinical recommendations to the guide assessment and management of ALBP.

In this episode, Amber Borucki, MD from Stanford Medicine, joins Host Sudheer Potru, DO, FASA, FASAM, and Co-Host Zafeer Baber, MD, to discuss acetaminophen use during pregnancy and childhood. They focus on a significant Swedish study that dispels myths about acetaminophen's links to autism, reinforcing its safety and effectiveness. Dr. Borucki highlights its role in pain management for expectant mothers and children, while the hosts discuss alternatives to opioids, like acetaminophen and ibuprofen, and stress the importance of consulting healthcare providers for proper dosing and guidance. About the Guest Dr. Amber Borucki is an anesthesiologist and pain medicine specialist focused on chronic pain management in children and young adults, particularly after surgery or due to chronic conditions. She earned her medical degree from Rush Medical College and completed her residency at the University of Chicago. Dr. Borucki also underwent fellowships in pediatric anesthesiology and adult/pediatric pain medicine at Boston Children's Hospital, Brigham Women's Hospital, and Beth Israel Deaconess Medical Center. After a year of private practice in Reno, Nevada, she spent five years at UCSF as a pediatric anesthesiologist and the Director of the Pediatric Anesthesia Service at UCSF Benioff Children's Hospital.    🔑 Key Takeaways  Acetaminophen is Safe: Current studies, including a large Swedish cohort, show no link between acetaminophen use in pregnancy and autism, reinforcing its safety profile. Importance of Treating Pain in Children: Dr. Borucki discusses the potential long-term adverse effects of untreated pain in pediatric patients, including increased risks of chronic pain and mood disorders. Dosing Caution: The significance of proper dosing is highlighted, emphasizing the need for a healthcare professional consultation, especially in young children. Combating Opioid Use: Acetaminophen serves as a valuable alternative in managing pain, potentially decreasing reliance on opioids post-surgery. Consult Reliable Sources: Listeners are encouraged to consult reputable organizations like the American Academy of Pediatrics for trustworthy medical advice. Resources American Academy of Pediatrics:  Acetaminophen is Safe for Children When Taken as Directed, No Link to AutismAmerican College of Obstetricians & Gynecologists: Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes Society for Pediatric Pain Medicine Video: Acetaminophen and autism: what is safe for children? *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

Episode Summary: In this compelling episode of the Pain Matters Podcast, hosts Sudheer Potru, DO, FASA, FASAM, and Zafeer Baber, MD, sit down with Jeremy Adler, DMSc, PA-C, DFAAPA, a seasoned Physician Assistant practicing at the UCSD Center for Pain Medicine in the field of pain medicine, to explore the evolving roles of advanced practice providers in the specialty. Jeremy shares insights from his 25-year career spanning private practice and academia, shedding light on the benefits and challenges of working in these different professional settings.  Jeremy Adler's engaging discussion highlights the multidimensional nature of medicine, emphasizing the importance of a multidisciplinary approach that includes APPs, anesthesiologists, psychologists, and more. This episode delves into the reasons behind the rising interest in APP roles, fueled by the pursuit of work-life balance and diverse practice opportunities across specialties. The conversation also explores the necessity of formalized education and training to equip PAs and NPs with the skills needed to excel in the complex landscape of pain medicine. About the Guest Jeremy A. Adler, DMSc, PA-C, DFAAPA|Dr. Jeremy Adler is a nationally recognized physician assistant with over 25 years of experience in pain management. He serves at UC San Diego Health’s Center for Pain Medicine and previously co-owned a private pain practice. A published author and national lecturer, he’s known for his advocacy in evidence-based, compassionate pain care and has earned honors including California State Assembly recognition and POCN’s 2022 Top Pain Management PA award. He also leads the American Academy of Pain Medicine Foundation and holds leadership roles in major professional organizations.  🔑 Key Takeaways: The significant growth in APP roles offers expanded opportunities, especially in specialties like pain medicine, where multidisciplinary collaboration is essential and the patient population is ever-growing. The transition from private practice to academia provides unique insights into differing healthcare dynamics, patient populations, and resource availability. A foundation in teamwork and continued education is crucial for true success and effectiveness in a team-based healthcare model. Advancements in APP practice have made it a rewarding career choice, especially for those seeking a balanced work-life and diverse professional experiences. Building strong communication channels within multidisciplinary teams is vital to navigating challenges and ensuring optimal patient care.Resources Jeremy A. Adler, DMSc, PA-C, DFAAPA: LinkedInJeremy A. Adler, DMSc, PA-C, DFAAPA, UCSD Center for Pain Medicine*Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

In this episode of Pain Matters, Shravani Durbhakula, MD, MPH, MBA, speaks with Maia Szalavitz, award-winning New York Times opinion writer and AAPM 2025 Featured Speaker. Recorded April 4, 2025, at the AAPM PainConnect 2025 meeting, their conversation explores themes from Szalavitz’s recent writing on addiction, harm reduction, and drug policy. Maia shares her personal journey through addiction and recovery, and offers insights into the critical distinction between dependence and addiction. They also discuss the effectiveness of harm reduction strategies when it comes to opioids, the potential of emerging treatments like Ozempic, and the role of media in shaping public understanding of addiction. Throughout, Szalavitz challenges traditional narratives and advocates for evidence-based, compassionate approaches to drug policy and treatment. She also offers tips for how medical professionals can make their voices heard.  *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.  About the Guest:  Maia Szalavitz Maia Szalavitz is an acclaimed journalist and author known for her expertise in addiction, harm reduction, and drug policy. Having personally experienced addiction, Szalavitz's work draws deeply from her own journey to recovery. Her celebrated books include "Unbroken Brain: A Revolutionary New Way of Understanding Addiction" and "Undoing Drugs: The Untold Story of Harm Reduction and the Future of Addiction." Szalavitz frequently contributes to major publications with opinion pieces that challenge traditional views on addiction and advocate for science-based approaches to drug policy.   Episode Summary:  🔑 Key Takeaways Addiction vs. Dependence: Szalavitz emphasizes the critical distinction between physical dependence and true addiction — a nuance often misunderstood in both policy and clinical settings.Harm Reduction Works: Szalavitz says that strategies like syringe exchange and safe use education are not just compassionate — they’re backed by evidence and save lives.Ozempic and New Treatments: The conversation touches on the potential of drugs like Ozempic in treating addiction, and what the early research suggests.Media’s Role: Fair and science-based journalism is essential — Szalavitz critiques the harm caused by sensationalized or "artificially balanced" reporting on drug use.Policy Reform: Current drug policies often criminalize rather than help — Szalavitz calls for systemic change rooted in public health, not punishment. Resources: Maia Szalavitz: Personal Website Books by Maia Szalavitz: Undoing Drugs, Unbroken Brain

Join Executive Producer and Host Shravani Durbhakula, MD, MPH, MBA, and Co-Host Mustafa Broachwala, DO, for a pivotal episode of the Pain Matters Podcast where we address the recent BMJ publication, “Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomized trials,” and the associated guideline. Steven Cohen, MD, Feinberg School of Medicine Northwestern University, Lynn R. Kohan, MD, University of VA Medical School, Zachary McCormick, MD, University of Utah, Nathaniel M. Schuster, MD, University of California, San Diego, Daniel Larach, MD, MS, MA, Vanderbilt University, Hance Clarke, MD, FRCPC, PhD, University of Toronto and President of the Canadian Pain Society, Hemant Kalia, MD, MPH, FIPP, Invision Health, and present diverse perspectives on the publication’s claims and the systematic review and meta-analysis methods behind it. In this episode, you’ll learn: The podcast underlines the necessity for comprehensive, unbiased systematic reviews and meta-analyses to inform clinical guidelines effectively.Experts caution against the misinterpretation of studies and the potential consequences for policy and access to interventional pain procedures.Advocates call for unified efforts in the pain medicine community to pursue legislative and regulatory reforms that align with current evidence and patient needs.The conversation underscores the pivotal role of personalized patient care and clinically validated techniques in improving outcomes and preserving practice legitimacy.The podcast highlights the risk of reducing access to viable interventional pain treatments if skewed interpretations of data shape healthcare policies.Tune in to discover how these leading experts address the controversies, advocate for robust clinical evidence, and highlight the urgent need for unified advocacy in shaping practical, patient-centered guidelines. Be sure to subscribe so you don’t miss our next episode. Reference:   Wang X, Martin G, Sadeghirad B, Chang Y, Florez I D, Couban R J et al. Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomised trials BMJ 2025; 388 :e079971 doi:10.1136/bmj-2024-079971 *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

Dr. Mark Wallace of UCSD joins hosts Shravani Durbhakula, MD, MPH, MBA and Mustafa Broachwala, DO and pick up where they left off on their discussion regarding the nuanced world of medical cannabis, understanding medical applications, appropriate dosing strategies, and advice for prescribing providers. Furthermore, they discuss the challenges of clinical trials, regulatory hurdles, and the implications for treating pain. Dr. Wallace offers insight into the complexities of cannabis research, dosage guidelines, and the controversial discourse surrounding its legalization. This enlightening discussion offers a deep dive into an oft misunderstood and stigmatized area of pain medicine. *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

Join us for an enlightening episode of the Pain Matters Podcast, where we dive deep into the world of medical cannabis and its implications for pain management.  Hosts Shravani Durbhakula, MD, MPH, MBA, and Mustafa Broachwala, DO, are joined by Mark Steven Wallace, MD, a Pain Management Specialist and Professor of Anesthesiology at UC San Diego Health, who brings more than two decades of experience in cannabis research. In this episode, you’ll discover:  Biologics of Cannabis: Dr. Wallace dives deep into the pathophysiologic mechanism at play regarding endocannabinoid receptors and the mechanism of actions of cannabis in the body, especially as it relates to pain.Medical Cannabis vs. Opioids: Dr. Wallace shares his observations on the lack of tolerance development in patients using medical marijuana compared to traditional opioids.Regulatory and Dosage Challenges: Insights into the complexities of prescribing and dosing medical marijuana, and how these factors impact patient care.Therapeutic Potential: Discussion on the conditions that respond well to medical cannabis based on current research and clinical experience.Patient Stories and Outcomes: Real-world examples of how medical cannabis has impacted patients' lives, particularly in managing chronic pain.Future of Cannabis in Medicine: Dr. Wallace's thoughts on the evolving landscape of medical cannabis research and its future potential in healthcare going forward.This episode is a must-listen for healthcare providers interested in understanding the nuanced role of cannabis in pain management and those looking to integrate evidence-based cannabinoid therapies into their practice. Be sure to subscribe so you don’t miss Part 2 of this nuanced discussion and to find out what’s next for medical cannabis in pain medicine.  *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

Join us for Part 2 of our engaging series on the necessary reforms in pain medicine training as we explore potential changes that could significantly enhance the quality and effectiveness of pain medicine education. Hosts Shravani Durbhakula, MD, MPH, MBA, and Mustafa Broachwala, DO are joined once again by esteemed experts Scott Gregory Pritzlaff, MD, Associate Professor and Pain Medicine Fellowship Director at UC Davis Health, and Sayed Emal Wahezi, MD, Professor and Pain Medicine Fellowship Director at Montefiore Medical Center, to delve deeper into the structural adjustments and implications of extending training periods in pain medicine. Tune in to hear: Structural Changes and Educational Enhancements: Discussing the risks & benefits of: extending fellowship duration,  truncating baseline specialty training years, creating a pain residency, re-establishing graduation case numbers, and more. How do we make training comprehensive and attract a more dedicated cohort of trainees?Diversity and Accessibility: Examining how changes in training duration might impact the diversity of applicants and accessibility of pain medicine as a specialty.Mentorship and Peer Learning: Highlighting the importance of mentorship and peer learning that changes in training could facilitate, enhancing both professional growth and patient care.Controversies and Challenges: Addressing the potential challenges and controversies associated with implementing longer training periods, such as funding, accreditation, and acceptance within the broader medical community.The Need for Collaboration: Discussing the need for a unified voice in pain medicine and collaboration across specialities and societies to achieve mutual advocacy goals & better training. This episode is critical for educators, trainees, and healthcare policymakers interested in understanding and shaping the future of pain medicine training. *Views expressed by our guests are their own and do not necessarily reflect those of the hosts, their institutions, or the American Academy of Pain Medicine.

Join us in a critical discussion on the urgent need for reform in pain medicine training programs.  In this enlightening episode of the Pain Matters Podcast, hosts Shravani Durbhakula, MD, MPH, MBA, and Mustafa Broachwala, DO, engage with experienced pain medicine program directors to delve deep into the current state, gaps, and proposed changes surrounding pain medicine fellowships. Tune in as we’re joined by Scott Gregory Pritzlaff, MD, Associate Professor and Pain Medicine Fellowship Director at UC Davis Health, and Sayed E. Wahezi, MD, Professor and Pain Medicine Fellowship Director at Montefiore Medical Center as well as a board member of the Association of Pain Program Directors, to share unique insights into the complexities of pain medicine training. In this episode, you'll hear about: The Current State of Pain Medicine Training: Insights into the existing structure of pain medicine training programs and their limitations.Challenges with Fellowship Durations: A detailed discussion on the implications of the current short durations of fellowships and how they may not adequately prepare physicians for the complexities of pain management.Interdisciplinary Education: The importance of integrating diverse medical disciplines within pain medicine training to enhance understanding and patient care.Potential Reforms: Proposals for extending fellowship durations and making pain medicine training more comprehensive and interdisciplinary.This discussion is essential for anyone involved in medical education, particularly those in pain medicine, who seeks to understand the future directions of training that could better prepare physicians for the evolving challenges in patient care. Please subscribe and turn on notifications to ensure you don’t miss part 2 of our Pain Medicine Training discussion.

Join us for a timely discussion on the recent Federal Trade Commission (FTC) ruling to ban non-compete clauses. This decision can significantly alter the landscape of employment across various sectors, including healthcare.  In this special episode of the Pain Matters Podcast, hosts Shravani Durbhakula, MD, MPH, MBA, and Mustafa Broachwala, DO, sit down with Michael Johnson, Jr., Esq. to dive deep into the nuances of this ruling, and what it means for medical professionals, especially those in pain medicine. Our expert guest, Michael Johnson, Jr., Esq., is a seasoned physician contract lawyer and owner of Michael Johnson Legal. He has counseled more than 1,000 physicians on contract law. His noteworthy Instagram features ongoing commentary on critical issues. Give him a follow @physiciancontracts. Michael provides a clear breakdown of the potential impacts and the legal intricacies involved. Tune in to hear: Overview of the FTC's Decision: What the FTC's ban on non-competes means in practice, and why it's not yet enforceable.Exceptions and Challenges: Discussion on specific exceptions to the rule, like the carveout for senior executives and how this might affect non-profit and for-profit healthcare entities differently.Implications for Physicians: How the ruling could change the dynamics of physician practice models, mobility, and employment negotiationsLegal and Economic Perspectives: Insight into the broader economic and legal debates surrounding non-compete clauses and their enforceability.Future of Physician Employment: Speculations on how this could lead to greater autonomy, innovation, and potential shifts in the healthcare employment landscape.This is a must-listen episode for all healthcare providers who are questioning how this federal agency rule will impact their future careers and opportunities.

Join us for a riveting exploration into the rapidly evolving world of artificial intelligence (AI) in interdisciplinary pain medicine. This episode of the Pain Matters Podcast features a thought-provoking discussion on the transformative potential of AI and the ethical challenges it introduces. Hosts Shravani Durbhakula, MD, MPH, MBA, and Mustafa Broachwala, DO, are joined by two distinguished experts: Tinglong Dai, PhD, a Bernard T. Ferrari Professor at Johns Hopkins Carey Business School, co-chair of the Johns Hopkins Workgroup on AI and Healthcare, and a leading voice in the integration of AI within clinical settings. Dr. Dai's extensive media presence and recognition as one of the World's Best 40 Under 40 Business School Professors by Poets & Quants underline his profound impact on AI education and application.Nestoras Mathioudakis, M.D., M.H.S., an Associate Professor of Medicine at Johns Hopkins School of Medicine, where his work focuses on medical applications of generative AI. As Co-Director of the Diabetes Prevention & Education Program and a seasoned educator in clinical informatics, Dr. Mathioudakis brings critical insights into the practical and ethical dimensions of AI in medicine.Tune in to discover: AI's Impact on Clinical Practices: Exploring how AI is currently being used to enhance clinical documentation, streamline insurance processes, and support decision-making in patient care.Ethical Considerations and Challenges: Discussing the complexities of data integrity, the potential biases in AI algorithms, and the ethical implications of AI in clinical decision support.The Future of AI in Medicine: Speculating on the future directions of AI in healthcare, including its role in personalized medicine and the ongoing need for rigorous validation and ethical oversight.Real-World Applications and Case Studies: Analyzing specific instances of AI application in healthcare, such as diagnostic support and predictive analytics, and evaluating their outcomes.Navigating the Regulatory Landscape: Understanding the implications of recent legal and regulatory developments affecting AI in healthcare.Find out how AI is reshaping healthcare delivery, enhancing patient outcomes, and posing new questions about the intersection of technology and medical ethics.  This discussion is crucial for healthcare providers looking to stay informed about the latest developments in AI and its impact on the field of pain medicine.

Join us for a comprehensive exploration into the advocacy and personal dedication that shapes the world of pain medicine.  In this episode, our discussion hones in on a critical juncture in pain medicine — the anticipation of the Washington Health Technology Clinical Committee's (HTCC) decision on Spinal Cord Stimulation (SCS) coverage. This decision could transform the landscape of pain management for state employees, state-sponsored health plans, and injured workers under Washington Labor and Industries (L&I), reaching over 2.5 million people. Hosts Shravani Durbhakula, MD, MPH, MBA, and Mustafa Broachwala, DO, are joined by a distinguished panel of guests: Brett R. Stacey, MD, from UW Medicine; and Steven Stanos, DO, and Fangfang Xing, MD, from Swedish Pain Services–all of whom were integral leaders as part of the Washington State Physicians State Spinal Cord Stimulation (SCS) Work Group. We also welcome Richard North, MD, from Johns Hopkins School of Medicine–a pioneer in the field of pain medicine and a historic advocate as it relates to neuromodulation and previous hearings regarding SCS in Washington State. Together, we’ll dive deep into the nuances and state of current and historic healthcare policies, the heroic advocacy work of the Washington State Physicians SCS Work Group, and the broader implications of the impending HTCC decision for providers and patients alike. In this episode, you'll learn: Historical Context: Context of the history of healthcare policy surrounding SCS in Washington StateThe Vital Role of the Washington State Physician SCS Work Group: A deep dive into the group's efforts and the importance of their advocacy in shaping healthcare policy for pain management in Washington state.Understanding the HTCC's Influence and Approach: A breakdown of the Washington HTCC's process, authority, and its critical role in determining the future of SCS coverage.Navigating Healthcare Policy in Washington: Insights into the state's healthcare coverage, including the unique aspects of its approach to technology and treatment coverage for a significant portion of its citizens.Journey to the HTCC Decision: The key milestones and advocacy efforts that have led to this momentous opportunity to influence pain treatment coverage.Implications for Pain Medicine Providers and Patients: Discussing what the HTCC's decision means for the community of pain medicine providers and the patients they serve. We also highlight the AAPM's support for the SCS coverage movement, emphasizing the potential positive impact on patient care and pain management practices.Tune in and stay informed, get involved, and understand the profound implications of these decisions on the quality of life for countless individuals. Remember, your involvement and awareness as a pain medicine provider contribute to the advancement and betterment of patient care across the nation. Note: At the 47:45 mark, we reference that the upcoming hearing is in January of 2024. While this was accurate at the time of the recording, this hearing has been pushed back. The final decision about coverage terms will occur after a meeting on  February 16, 2024.

On this episode of the Pain Matters Podcast, we turn our attention to a Viewpoint article published in JAMA on December 18, 2023 entitled “Corporate Influences on Science and Health—the Case of Spinal Cord Stimulation”. Written by the same lead author of the widely criticized Cochrane Review of Spinal Cord Stimulation (SCS) for Low Back Pain, this recent article blames all physicians who defend SCS for having corporate interests and suggests that no research in any specialty should be influenced by industry. Hosts Shravani Durbhakula, MD, MPH, MBA, and Mustafa Broachwala, DO, sit down with Nathaniel M. Schuster, MD, from UC San Diego Health. All are authors to responses in Pain Medicine to the Cochrane Review by Traeger et al. –see Pain Matters Episode 21 and articles PMID: 37067491 & PMID: 37195450 by Durbhakula et al. This episode responds to the questionable allegations made by Traeger et al., questioning the integrity of all SCS research and the pain physicians who utilize SCS for patients. We do a fact-check on the JAMA article and take a deep dive into understanding the true nature of corporate influences on SCS. In this episode, you'll gain insights into: Critiquing Corporate Influence: Dr. Schuster and our hosts examine corporate influence in pain medicine research, particularly in the context of SCS treatments for low back pain.False Dichotomies in SCS Research: The false dichotomy that physician-scientists who may engage with industry at any level cannot be industry-independent when speaking on the subject of SCS.Physician Scientist Integrity: False accusations, including that ALL physicians who responded to the Cochrane Review by Traeger et al,. were influenced by industry.Publishing SCS Research: The by Traeger et al. that academic journals should never publish anything with industry ties – in SCS or any field of medicine.Reality of SCS Funding: Understanding the intricacies of device research funding as well as the limitations of funding outside of industry (e.g., government funding) and contextualizing the paucity of placebo- or sham-controlled studies.Ethics in Academic Societies: Clarifying the policies surrounding conflicts of interest amongst academic societies.Debunking Hara et al.: Understanding the methodologic flaws of the Hara et al. study of SCS for Chronic Radicular Pain After Lumbar Spine Surgery.Listen in as we navigate these complex waters, aiming to provide a balanced perspective on the interplay between industry funding, scientific research, and clinical practice in pain medicine.  This episode is a must-listen for anyone looking to understand the multifaceted nature of pain medicine in today's healthcare landscape. CORRECTION (11:10-11:50): SCS for FDA requires a premarket approval (PMA). There is no need for clinical data if it is possible to prove equivalence. For external powered devices where RF is the predicate device, FDA 510k pathway is required.